12:33 PM
 | 
Feb 05, 2019
 |  BC Extra  |  Company News

FDA psychiatry product division director joins Allergan

Following a 12-year tenure as director of FDA’s Division of Psychiatry Products, Mitchell Mathis has joined Allergan plc (NYSE:AGN) as CMO for CNS products.

Mathis left FDA on Jan. 19 and joined Allergan later in the month.

Tiffany Farchione, deputy director of the FDA division, is serving as acting director.

At FDA,...

Read the full 249 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >